Adakveo

Medicinal product

(Invented) name

Adakveo

Active substance (s)

Krizanlizumabas

Strength

10 mg/ml

Pharmaceutical form

koncentratas infuziniam tirpalui

Route (s) of administration

leisti į veną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

B06AX01, crizanlizumab

Marketing authorisation holder

Novartis Europharm Ltd., Airija

Date of authorisation

2020-10-28

Date of renewal

Documents

Search in EMA Europe

Stage

Išregistruotas

Controlled?

No

Controlled substance type

Legal basis

8(3)

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Concentrate for solution for infusion	1 ml
Krizanlizumabas	10 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
105242	91344	1091344	flakonas	10 ml N1		Receptinis	EU/1/20/1476/001	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2023-08-02	Išregistruotas
2020-10-28	Registruotas